All Stories

  1. Infectious Diseases Society of America (IDSA) Position Statement: Why IDSA Did Not Endorse the Community-Acquired Pneumonia Guidelines 2025 Update

    Article • Clinical Infectious Diseases, December 2025, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  2. Implementation of a pilot program of interprofessional education in infection prevention

    Article • Infection Control, October 2025, Cambridge University Press

    Prof. Majdi Al-Hasan

  3. The New Reality of Infective Endocarditis: Changes in Patient Demographics and Outcomes in South Carolina

    Article • Infectious Disease Reports, June 2025, MDPI AG

    Prof. Majdi Al-Hasan

  4. Association Between Reporting Antimicrobial Use and Clostridioides difficile Standardized Infection Ratios in South Carolina Hospitals

    Article • Pharmacy, February 2025, MDPI AG

    Prof. Majdi Al-Hasan

  5. Appropriateness of ambulatory antibiotic prescribing in South Carolina, 2012–2017

    Article • Antimicrobial Stewardship & Healthcare Epidemiology, January 2025, Cambridge University Press

    Prof. Majdi Al-Hasan

  6. Oral switch antibiotic therapy in uncomplicated Enterococcus faecalis bloodstream infection

    Article • JAC-Antimicrobial Resistance, December 2024, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  7. Missed Opportunities for Early De-Escalation of Antipseudomonal Beta-Lactam Antimicrobial Therapy in Enterobacterales Bloodstream Infection

    Article • Antibiotics, October 2024, MDPI AG

    Prof. Majdi Al-Hasan

  8. WHO global research priorities for antimicrobial resistance in human health

    Article • The Lancet Microbe, August 2024, Elsevier

    Prof. Majdi Al-Hasan, Professor karel allegaert

  9. Incidence and predictors of complications in Gram-negative bloodstream infection

    Article • Infection, March 2024, Springer Science + Business Media

    Prof. Majdi Al-Hasan

  10. Evaluation of the diagnostic utility of metagenomic next-generation sequencing testing for pathogen identification in infected hosts: a retrospective cohort study

    Article • Therapeutic Advances in Infectious Disease, January 2024, SAGE Publications

    Prof. Majdi Al-Hasan

  11. The prevalence of gram-negative bacteria with difficult-to-treat resistance and utilization of novel β-lactam antibiotics in the southeastern United States

    Article • Antimicrobial Stewardship & Healthcare Epidemiology, January 2024, Cambridge University Press

    Prof. Majdi Al-Hasan

  12. 750. Launching the South Carolina Regional Infection Prevention Training (SCRIPT) Center: A Pilot in Interprofessional Education

    Article • Open Forum Infectious Diseases, November 2023, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  13. 2763. Evaluating the Safety and Effectiveness of Long-term Antibiotic Suppression in Patients with Left Ventricular Assist Devices

    Article • Open Forum Infectious Diseases, November 2023, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  14. 2399. Changing Demographics of Infective Endocarditis in South Carolina: An Ecological Study

    Article • Open Forum Infectious Diseases, November 2023, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  15. Application of Precision Medicine Concepts in Ambulatory Antibiotic Management of Acute Pyelonephritis

    Article • Pharmacy, October 2023, MDPI AG

    Prof. Majdi Al-Hasan

  16. Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action

    Article • World Journal of Emergency Surgery, October 2023, Springer Science + Business Media

    Prof. Majdi Al-Hasan, Yusuff Adebisi, Dr Enrique Castro-Sánchez, Prof. Joseph O Fadare

  17. Interventions in the management of diabetes‐related foot infections: A systematic review

    Article • Diabetes/Metabolism Research and Reviews, October 2023, Wiley

    Prof. Majdi Al-Hasan

  18. IWGDF/IDSA Guidelines on the Diagnosis and Treatment of Diabetes-related Foot Infections (IWGDF/IDSA 2023)

    Article • Clinical Infectious Diseases, October 2023, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  19. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes‐related foot infections (IWGDF/IDSA 2023)

    Article • Diabetes/Metabolism Research and Reviews, October 2023, Wiley

    Prof. Majdi Al-Hasan

  20. Diagnosis of infection in the foot of patients with diabetes: A systematic review

    Article • Diabetes/Metabolism Research and Reviews, September 2023, Wiley

    Prof. Majdi Al-Hasan

  21. Intravenous versus Partial Oral Antibiotic Therapy in the Treatment of Uncomplicated Bloodstream Infection Due to Streptococcus Species

    Article • Microorganisms, September 2023, MDPI AG

    Prof. Majdi Al-Hasan

  22. Optimization of Empirical Antimicrobial Therapy in Enterobacterales Bloodstream Infection Using the Extended-Spectrum Beta-Lactamase Prediction Score

    Article • Antibiotics, June 2023, MDPI AG

    Prof. Majdi Al-Hasan

  23. Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, January 2023, Wiley

    Prof. Majdi Al-Hasan

  24. Ecologic analysis of antimicrobial use in South Carolina hospitals during 2020–2022

    Article • Antimicrobial Stewardship & Healthcare Epidemiology, January 2023, Cambridge University Press

    Prof. Majdi Al-Hasan

  25. Epidemiology, Outcomes and Tolerability of Protracted Treatment of Nontuberculous Mycobacterial Infections at a Community Teaching Hospital in the Southeastern United States

    Article • Antibiotics, November 2022, MDPI AG

    Prof. Majdi Al-Hasan

  26. Paradoxical outcomes of gram‐negative bloodstream infection in solid organ transplant recipients

    Article • Transplant Infectious Disease, November 2022, Wiley

    Prof. Majdi Al-Hasan

  27. The progression of sepsis from physiologic systemic inflammatory response to immune dysregulation due to life-threatening infections

    Article • Exploration of Immunology, October 2022, Open Exploration Publishing

    Prof. Majdi Al-Hasan

  28. Weighing the odds of Bloodstream Infection. What is the Perfect Model to Predict this Risk?

    Article • Clinical Microbiology and Infection, September 2022, Elsevier

    Prof. Majdi Al-Hasan

  29. Temporal Association between Influenza Vaccination Coverage and Ambulatory Antibiotic Use in Children

    Article • The Pediatric Infectious Disease Journal, April 2022, Wolters Kluwer Health

    Prof. Majdi Al-Hasan

  30. It is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional survey

    Article • World Journal of Emergency Surgery, March 2022, Springer Science + Business Media

    Prof. Majdi Al-Hasan, Professor Dr. Ashrarur Rahman Mitul, Alfie J Kavalakat, Professor Stefano Di Bella, Evgeni Dimitrov, Dr Timothy Craig Hardcastle

  31. Evaluation of early clinical failure criteria in Enterococcus species bloodstream infection

    Article • Infection, January 2022, Springer Science + Business Media

    Prof. Majdi Al-Hasan

  32. Show me the data: A statewide comparative report of National Healthcare Safety Network (NHSN) Antimicrobial Use Option standardized antimicrobial administration ratios (SAARs)

    Article • Antimicrobial Stewardship & Healthcare Epidemiology, January 2022, Cambridge University Press

    Prof. Majdi Al-Hasan

  33. Candida parapsilosis bloodstream infection in an immunocompromised host with discordant multiplex polymerase chain reaction and conventional blood culture results: a case report

    Article • Therapeutic Advances in Infectious Disease, January 2022, SAGE Publications

    Prof. Majdi Al-Hasan

  34. Clinical Utility and Cost Effectiveness of Long-Acting Lipoglycopeptides Used in Deep-Seated Infections among Patients with Social and Economic Barriers to Care

    Article • Pharmacy, December 2021, MDPI AG

    Prof. Majdi Al-Hasan

  35. Prediction of Mortality in Staphylococcus aureus Bloodstream Infection using Quick Pitt Bacteremia Score

    Article • Journal of Infection, December 2021, Elsevier

    Prof. Majdi Al-Hasan

  36. 44. Cost Effectiveness and Clinical Outcomes of Long Acting Lipoglycopeptides Used in Transitions of Care for Deep-Seated Infections

    Article • Open Forum Infectious Diseases, November 2021, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  37. 1298. Validation of Local Pseudomonas aeruginosa Risk Factors in Patients with Community-Onset Bacterial Pneumonia

    Article • Open Forum Infectious Diseases, November 2021, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  38. 1388. Epidemiology and Treatment Outcomes of Nontuberculous Mycobacterial Infections at a Community Teaching Hospital in the Southeastern United States

    Article • Open Forum Infectious Diseases, November 2021, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  39. Change in Antimicrobial Use during COVID-19 Pandemic in South Carolina Hospitals: A Multicenter Observational Cohort Study

    Article • International Journal of Antimicrobial Agents, October 2021, Elsevier

    Prof. Majdi Al-Hasan

  40. A pandemic recap: lessons we have learned

    Article • World Journal of Emergency Surgery, September 2021, Springer Science + Business Media

    Prof. Majdi Al-Hasan, Evgeni Dimitrov, MD Massimo Girardis, Dr Timothy Craig Hardcastle

  41. Impact of follow up blood cultures on outcomes of patients with community-onset gram-negative bloodstream infection

    Article • EClinicalMedicine, April 2021, Elsevier

    Prof. Majdi Al-Hasan

  42. Application of Standardized Antimicrobial Administration Ratio as a Motivational Tool within a Multi-Hospital Healthcare System

    Article • Pharmacy, February 2021, MDPI AG

    Prof. Majdi Al-Hasan

  43. Novel method of calculating adjusted antibiotic use by microbiological burden

    Article • Infection Control, January 2021, Cambridge University Press

    Prof. Majdi Al-Hasan

  44. Risk and Clinical Outcomes of Acute Myocardial Infarction and Acute Ischemic Stroke following Gram-Negative Bloodstream Infection

    Article • International Journal of Cardiology Hypertension, January 2021, Elsevier

    Prof. Majdi Al-Hasan

  45. Gram-Negative Bloodstream Infection: Implications of Antimicrobial Resistance on Clinical Outcomes and Therapy

    Article • Antibiotics, December 2020, MDPI AG

    Prof. Majdi Al-Hasan

  46. Clostridioides difficile infection and antibiotic prescription rates in the community: Explaining the gender gap

    Article • Infection Control, November 2020, Cambridge University Press

    Prof. Majdi Al-Hasan

  47. Motivational Application of Standardized Antimicrobial Administration Ratios Within a Healthcare System

    Article • Infection Control, October 2020, Cambridge University Press

    Prof. Majdi Al-Hasan

  48. 243. Temporal Trends in Appropriateness of Ambulatory Antibiotic Prescribing in South Carolina

    Article • Open Forum Infectious Diseases, October 2020, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  49. 290. Impact of follow up blood cultures on outcomes of patients with gram-negative bloodstream infections

    Article • Open Forum Infectious Diseases, October 2020, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  50. 313. Using a Clinical Decision Prediction Tool to Improve Empirical Antimicrobial Therapy in Ceftriaxone-Resistant Enterobacterales Bloodstream Infections

    Article • Open Forum Infectious Diseases, October 2020, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  51. 955. Addressing Gaps and Disparities in HIV testing in the Emergency Department

    Article • Open Forum Infectious Diseases, October 2020, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  52. Regulatory Approval, Implementation, and Brief Assessment of a Pharmacist- and Pharmacy Trainee-Administered Penicillin Allergy Assessment and Skin Testing Program

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, August 2020, Wiley

    Prof. Majdi Al-Hasan

  53. Use of Antibiotics in Chronic Obstructive Pulmonary Disease: What is Their Current Role in Older Patients?

    Article • Drugs & Aging, July 2020, Springer Science + Business Media

    Prof. Majdi Al-Hasan

  54. Regional and statewide antibiograms as targeted interventions against antibiotic resistance

    Article • Infection Control, June 2020, Cambridge University Press

    Prof. Majdi Al-Hasan

  55. Temporal trends in ambulatory antibiotic prescription rates in South Carolina: Impact of age, gender, and resident location

    Article • Infection Control, June 2020, Cambridge University Press

    Prof. Majdi Al-Hasan

  56. Multicenter, Observational Cohort Study Evaluating Third-Generation Cephalosporin Therapy for Bloodstream Infections Secondary to Enterobacter, Serratia, and Citrobacter Species

    Article • Antibiotics, May 2020, MDPI AG

    Prof. Majdi Al-Hasan

  57. Pharmacist-Driven Culture and Sexually Transmitted Infection Testing Follow-Up Program in the Emergency Department

    Article • Pharmacy, April 2020, MDPI AG

    Prof. Majdi Al-Hasan

  58. Impact of Reappraisal of Fluoroquinolone Minimum Inhibitory Concentration Susceptibility Breakpoints in Gram-Negative Bloodstream Isolates

    Article • Antibiotics, April 2020, MDPI AG

    Prof. Majdi Al-Hasan

  59. Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Moving Target

    Article • Clinical Infectious Diseases, April 2020, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  60. RISK OF ACUTE MYOCARDIAL INFARCTIONS AND ACUTE ISCHEMIC STROKES FOLLOWING GRAM-NEGATIVE BLOODSTREAM INFECTIONS

    Article • Journal of the American College of Cardiology, March 2020, Elsevier

    Prof. Majdi Al-Hasan

  61. Evaluating appropriateness and diagnostic stewardship opportunities of multiplex polymerase chain reaction gastrointestinal testing within a hospital system

    Article • Therapeutic Advances in Infectious Disease, January 2020, SAGE Publications

    Prof. Majdi Al-Hasan

  62. Empirical Fluoroquinolones versus Broad-Spectrum Beta-Lactams for Gram-Negative Bloodstream Infections in the Absence of Antimicrobial Resistance Risk Factors

    Article • Journal of Global Antimicrobial Resistance, December 2019, Elsevier

    Prof. Majdi Al-Hasan

  63. Burden of community-associated Clostridioides difficile infection in southeastern United States: a population-based study

    Article • Infection, November 2019, Springer Science + Business Media

    Prof. Majdi Al-Hasan

  64. Prediction of Sulfamethoxazole/Trimethoprim Resistance in Community-Onset Urinary Tract Infections

    Article • Journal of Global Antimicrobial Resistance, November 2019, Elsevier

    Prof. Majdi Al-Hasan

  65. Erratum

    Article • Clinical Infectious Diseases, October 2019, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  66. 2733. Association Between Influenza Vaccination Coverage and Ambulatory Antibiotic Prescription Rates in Children in South Carolina

    Article • Open Forum Infectious Diseases, October 2019, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  67. 122. Evaluation of Early Clinical Failure Criteria in Patients with Enterococcus Species Bloodstream Infection

    Article • Open Forum Infectious Diseases, October 2019, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  68. 851. Validation of Quick Pitt Bacteremia Score in Patients with Staphylococcus aureus Bloodstream Infection

    Article • Open Forum Infectious Diseases, October 2019, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  69. Direct Measurement of Performance: A New Era in Antimicrobial Stewardship

    Article • Antibiotics, August 2019, MDPI AG

    Prof. Majdi Al-Hasan

  70. COPD Exacerbations — A Target for Antibiotic Stewardship

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 2019, New England Journal of Medicine (NEJM/MMS)

    Prof. Majdi Al-Hasan

  71. Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates

    Article • International Journal of Antimicrobial Agents, July 2019, Elsevier

    Prof. Majdi Al-Hasan

  72. Resilience of the Pitt Bacteremia Score: Three Decades and Counting

    Article • Clinical Infectious Diseases, June 2019, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  73. Syndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agents

    Article • American Journal of Infection Control, June 2019, Elsevier

    Prof. Majdi Al-Hasan

  74. Oral antibiotics for uncomplicated and complicated bloodstream infections

    Article • Clinical Microbiology and Infection, May 2019, Elsevier

    Prof. Majdi Al-Hasan

  75. Evaluation of early clinical failure criteria for gram-negative bloodstream infections

    Article • Clinical Microbiology and Infection, May 2019, Elsevier

    Prof. Majdi Al-Hasan

  76. A Baker’s Dozen of Top Antimicrobial Stewardship Publications in 2016

    Article • March 2019, MDPI AG

    Prof. Majdi Al-Hasan

  77. Association Between Body Mass Index and Mortality in Patients With Gram-Negative Bloodstream Infections

    Article • Infectious Diseases in Clinical Practice, March 2019, Wolters Kluwer Health

    Prof. Majdi Al-Hasan

  78. Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection

    Article • Infection, February 2019, Springer Science + Business Media

    Prof. Majdi Al-Hasan

  79. Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals

    Article • Antibiotics, February 2019, MDPI AG

    Prof. Majdi Al-Hasan

  80. 645

    Article • Critical Care Medicine, January 2019, Wolters Kluwer Health

    Prof. Majdi Al-Hasan

  81. Bloodstream Infection due to Piperacillin/Tazobactam Non-Susceptible, Cephalosporin-Susceptible Escherichia coli: A Missed Opportunity for De-Escalation of Therapy

    Article • Antibiotics, December 2018, MDPI AG

    Prof. Majdi Al-Hasan

  82. 475. Burden of Clostridium difficile Infection in South Carolina: A Population-Based Study

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  83. 1043. Evaluation of Early Clinical Failure Criteria for Gram-Negative Bloodstream Infections

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  84. 975. Clostridium difficile Infection and Antibiotic Prescription Rates in the Community: Explaining the Gender Gap

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  85. Early de-escalation of antimicrobial therapy reduces risk of C. difficile infection

    Article • Clinical Infectious Diseases, October 2018, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  86. Minimum Acceptable Susceptibility of Empirical Antibiotic Regimens for Gram-Negative Bloodstream Infections

    Article • Infectious Diseases in Clinical Practice, September 2018, Wolters Kluwer Health

    Prof. Majdi Al-Hasan

  87. Ignoring the Elephant: Does the Infectious Diseases Society of America Support Sepsis-3 or Pre-sepsis Criteria?

    Article • Clinical Infectious Diseases, August 2018, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  88. Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case–case–control study

    Article • Infection, May 2018, Springer Science + Business Media

    Prof. Majdi Al-Hasan

  89. Reply to comments: duration of antimicrobial therapy for Gram-negative bacteremia secondary to urinary source of infection

    Article • Infection, February 2018, Springer Science + Business Media

    Prof. Majdi Al-Hasan

  90. Duration of Antimicrobial Therapy for Enterobacteriaceae Bacteremia: Using Convenient End Points for Convenient Conclusions

    Article • Clinical Infectious Diseases, January 2018, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  91. Got penicillin allergy? Carbapenems are not the answer

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, December 2017, Wiley

    Prof. Majdi Al-Hasan

  92. A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway

    Article • Surgical Infections, November 2017, Mary Ann Liebert Inc

    Dr Timothy Craig Hardcastle, Prof. Majdi Al-Hasan, MD Massimo Girardis, Francesco Di Marzo, Dr Salomone Di Saverio

  93. Combination antimicrobial therapy for gram-negative bloodstream infections?

    Article • International Journal of Antimicrobial Agents, September 2017, Elsevier

    Prof. Majdi Al-Hasan

  94. Erratum to: Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)

    Article • World Journal of Emergency Surgery, August 2017, Springer Science + Business Media

    Prof. Majdi Al-Hasan

  95. The Global Alliance for Infections in Surgery: defining a model for antimicrobial stewardship—results from an international cross-sectional survey

    Article • World Journal of Emergency Surgery, August 2017, Springer Science + Business Media

    Prof. Majdi Al-Hasan, Dr Timothy Craig Hardcastle, Francesco Di Marzo, Andras Vereczkei, Souha Kanj, Dr Hong Bin Kim

  96. Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence

    Article • Hospital Pharmacy, July 2017, SAGE Publications

    Prof. Majdi Al-Hasan

  97. The Magic Formula: Optimizing Care While Using Less Broad-Spectrum Antibiotics

    Article • Antimicrobial Agents and Chemotherapy, June 2017, ASM Journals

    Prof. Majdi Al-Hasan, Brandon Bookstaver

  98. For Bloodstream Infections: Optimize, Do Not Minimize

    Article • Infection, May 2017, Springer Science + Business Media

    Prof. Majdi Al-Hasan

  99. Prediction of fluoroquinolone resistance in patients with complicated urinary tract infections

    Article • Antimicrobial Agents and Chemotherapy, February 2017, ASM Journals

    Prof. Majdi Al-Hasan

  100. When to use empirical anti-pseudomonal therapy?

    Article • Diagnostic Microbiology and Infectious Disease, January 2017, Elsevier

    Prof. Majdi Al-Hasan

  101. Microbiologic Predictors of Pelvic Osteomyelitis Related to Decubitus Ulcers

    Article • Open Forum Infectious Diseases, January 2017, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  102. Microbiology of Vertebral Osteomyelitis and Implications on Empiric Therapy

    Article • Open Forum Infectious Diseases, January 2017, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  103. A Simplified Pitt Bacteremia Score (qPitt) to Predict Mortality in Patients with Gram-negative Bloodstream Infection

    Article • Open Forum Infectious Diseases, January 2017, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  104. The ESBL Prediction Score

    Article • Infection Control, December 2016, Cambridge University Press

    Prof. Majdi Al-Hasan

  105. Non-tuberculous mycobacterial bloodstream infections in patients with indwelling vascular catheters – the role of sickle cell anaemia

    Article • Infectious Diseases, December 2016, Taylor & Francis

    Prof. Majdi Al-Hasan

  106. Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae

    Article • American Journal of Infection Control, December 2016, Elsevier

    Prof. Majdi Al-Hasan

  107. Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections

    Article • International Journal of Antimicrobial Agents, November 2016, Elsevier

    Prof. Majdi Al-Hasan

  108. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis

    Article • Journal of Antimicrobial Chemotherapy, September 2016, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  109. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)

    Article • World Journal of Emergency Surgery, July 2016, Springer Science + Business Media

    Prof. Majdi Al-Hasan, Professor Dr Mainul Haque, Andras Vereczkei

  110. Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli

    Article • Journal of Chemotherapy, July 2016, Taylor & Francis

    Prof. Majdi Al-Hasan

  111. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections

    Article • Antimicrobial Agents and Chemotherapy, February 2016, ASM Journals

    Prof. Majdi Al-Hasan

  112. Validation of Fluoroquinolone Resistance Score in Patients With Complicated Urinary Tract Infections

    Article • Open Forum Infectious Diseases, January 2016, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  113. Optimal Duration of Antimicrobial Therapy for Bloodstream Infections Due to Gram-Negative Bacilli

    Article • Open Forum Infectious Diseases, January 2016, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  114. Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization

    Article • Clinical Microbiology and Infection, September 2015, Elsevier

    Prof. Majdi Al-Hasan

  115. Osteomyelitis After Open Fractures Adjusting Prophylactic Antimicrobial Therapy

    Article • Open Forum Infectious Diseases, January 2015, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  116. Effectiveness of Oral Antibiotics for Definitive Therapy of Gram-Negative Bloodstream Infections

    Article • Open Forum Infectious Diseases, January 2015, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  117. Prediction of Fluoroquinolone Resistance in Patients With Gram-Negative Bloodstream Infection

    Article • Open Forum Infectious Diseases, January 2015, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  118. Combination Versus Monotherapy for Gram-Negative Bloodstream Infections: Matching by Predicted Prognosis

    Article • Open Forum Infectious Diseases, January 2015, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  119. Association Between Inappropriate Empirical Antimicrobial Therapy and Hospital Length of Stay in Gram-Negative Bloodstream Infections

    Article • Open Forum Infectious Diseases, January 2015, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  120. Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle for Local Management of Gram-Negative Bloodstream Infections

    Article • Open Forum Infectious Diseases, January 2015, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  121. Bloodstream Infections and Central Line–Associated Bloodstream Infections

    Article • Surgical Clinics of North America, December 2014, Elsevier

    Prof. Majdi Al-Hasan

  122. Antibiotics save lives

    Article • Antimicrobial Agents and Chemotherapy, October 2014, ASM Journals

    Prof. Majdi Al-Hasan

  123. External validation of bloodstream infection mortality risk score in a population-based cohort

    Article • Clinical Microbiology and Infection, September 2014, Elsevier

    Prof. Majdi Al-Hasan

  124. 715Impact of Fluoroquinolone Resistance on Community-Onset Gram-Negative Bloodstream Infections

    Article • Open Forum Infectious Diseases, January 2014, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  125. 225Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence

    Article • Open Forum Infectious Diseases, January 2014, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  126. 1705Non-Tuberculous Mycobacterial Bloodstream Infections in Patients with In-Dwelling Vascular Access Catheters- Role of Sickle Cell Disease

    Article • Open Forum Infectious Diseases, January 2014, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  127. Community-acquired Methicillin-resistant Staphylococcus aureus Prostatic Abscesses

    Article • The American Journal of the Medical Sciences, October 2013, Elsevier

    Prof. Majdi Al-Hasan

  128. Predictive scoring model of mortality in Gram-negative bloodstream infection

    Article • Clinical Microbiology and Infection, October 2013, Elsevier

    Prof. Majdi Al-Hasan

  129. Asthma and risk of non-respiratory tract infection: a population-based case–control study

    Article • BMJ Open, October 2013, BMJ

    Prof. Majdi Al-Hasan

  130. Temporal Trends, Clinical Characteristics, and Outcomes of Histoplasmosis in a Tertiary Care Center in Kentucky, 2000 to 2009

    Article • Journal of the International Association of Providers of AIDS Care (JIAPAC), September 2013, SAGE Publications

    Prof. Majdi Al-Hasan

  131. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe

    Article • Clinical Microbiology and Infection, June 2013, Elsevier

    Prof. Majdi Al-Hasan

  132. Asthma and Risk of Community-Acquired Blood Stream Infection Caused by Escherichia Coli: A Population-Based Case-Control Study

    Article • Journal of Allergy and Clinical Immunology, February 2013, Elsevier

    Prof. Majdi Al-Hasan

  133. Asthma and Severity of Blood Stream Infection Caused by Escherichia coli: A Population-Based Study

    Article • Journal of Allergy and Clinical Immunology, February 2012, Elsevier

    Prof. Majdi Al-Hasan

  134. Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based study

    Article • European Journal of Clinical Microbiology & Infectious Diseases, October 2011, Springer Science + Business Media

    Prof. Majdi Al-Hasan

  135. Impact of Gram-Negative Bloodstream Infection on Long-Term Allograft Survival After Kidney Transplantation

    Article • Transplantation, June 2011, Wolters Kluwer Health

    Prof. Majdi Al-Hasan

  136. Temporal trends in Enterobacter species bloodstream infection: a population-based study from 1998–2007

    Article • Clinical Microbiology and Infection, April 2011, Elsevier

    Prof. Majdi Al-Hasan

  137. Cefepime effectiveness in Gram-negative bloodstream infections

    Article • Journal of Antimicrobial Chemotherapy, March 2011, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  138. Influence of referral bias on the clinical characteristics of patients with Gram-negative bloodstream infection

    Article • Epidemiology and Infection, February 2011, Cambridge University Press

    Prof. Majdi Al-Hasan

  139. Epidemiology and outcome of Gram-negative bloodstream infection in children: a population-based study

    Article • Epidemiology and Infection, July 2010, Cambridge University Press

    Prof. Majdi Al-Hasan

  140. Recurrent gram-negative bloodstream infection: A 10-year population-based cohort study

    Article • Journal of Infection, July 2010, Elsevier

    Prof. Majdi Al-Hasan

  141. Bacteremia complicating gram-negative urinary tract infections: A population-based study

    Article • Journal of Infection, April 2010, Elsevier

    Prof. Majdi Al-Hasan

  142. Epidemiology and Outcome of Klebsiella Species Bloodstream Infection: A Population-Based Study

    Article • Mayo Clinic Proceedings, February 2010, Elsevier

    Prof. Majdi Al-Hasan

  143. Are E. coli infections more common in the summer?

    Article • Clinical Microbiology and Infection, October 2009, Elsevier

    Prof. Majdi Al-Hasan

  144. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007

    Article • Journal of Antimicrobial Chemotherapy, May 2009, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan

  145. Incidence Rate and Outcome of Gram-Negative Bloodstream Infection in Solid Organ Transplant Recipients

    Article • Arabian archaeology and epigraphy, April 2009, Elsevier

    Prof. Majdi Al-Hasan

  146. β-Lactam and Fluoroquinolone Combination Antibiotic Therapy for Bacteremia Caused by Gram-Negative Bacilli

    Article • Antimicrobial Agents and Chemotherapy, January 2009, ASM Journals

    Prof. Majdi Al-Hasan

  147. Incidence of Pseudomonas aeruginosa Bacteremia: A Population-Based Study

    Article • The American Journal of Medicine, August 2008, Elsevier

    Prof. Majdi Al-Hasan

  148. Invasive Enteric Infections in Hospitalized Patients With Underlying Strongyloidiasis

    Article • American Journal of Clinical Pathology, October 2007, Oxford University Press (OUP)

    Prof. Majdi Al-Hasan